Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Essential1: PRAX-944 in Essential Tremor
NCT05021991Phase 2Completed
- Sponsor
- Praxis Precision Medicines
- Start
- Oct 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ulixacaltamide in essential tremor (ET), sponsored by Praxis Precision Medicines. Started Oct 2021; status: completed.
02
Drugs
ulixacaltamide
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT05021991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021991.